Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Medicines register
Registers Clinical trials Drugs API
Registers› Irish medicines ›Laboratorios Liconsa S.A.
Medicines register · Ireland

Laboratorios Liconsa S.A. — licensed medicines

17 medicines held by Laboratorios Liconsa S.A. on the Irish market, from the HPRA register.

Download CSV
Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,295 authorised products are in this register. Synced 04 Oct 2026, 10:12 UTC
Narrow the register Reset
Matches brand name, active substance, licence holder and licence number.
Browse by first letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
17 of 10,295 medicines
Download
Medicine
Active substance
Licence holder
Status
Atorvastatin Liconsa 10 mg film-coated tablets PA1239/028/001
Atorvastatin calcium trihydrate
Laboratorios Liconsa S.A.
Not marketed
Atorvastatin Liconsa 20 mg film-coated tablets PA1239/028/002
Atorvastatin calcium trihydrate
Laboratorios Liconsa S.A.
Not marketed
Atorvastatin Liconsa 40 mg film-coated tablets PA1239/028/003
Atorvastatin calcium trihydrate
Laboratorios Liconsa S.A.
Not marketed
Atorvastatin Liconsa 80 mg film-coated tablets PA1239/028/004
Atorvastatin calcium trihydrate
Laboratorios Liconsa S.A.
Not marketed
Formoterol 12 micrograms inhalation powder, hard capsule PA1239/001/001
Formoterol fumarate
Laboratorios LICONSA, S.A.
Not marketed
Mirpresoc 20 mg Tablets PA1239/017/001
Telmisartan
Laboratorios Liconsa S.A.
Not marketed
Mirpresoc 40 mg Tablets PA1239/017/002
Telmisartan
Laboratorios Liconsa S.A.
Not marketed
Mirpresoc 80 mg Tablets PA1239/017/003
Telmisartan
Laboratorios Liconsa S.A.
Not marketed
Tapentadol Liconsa 100 mg prolonged-release tablets PA1239/029/003
Tapentadol tartrate
Laboratorios Liconsa S.A.
Not marketed
Tapentadol Liconsa 150 mg prolonged-release tablets PA1239/029/004
Tapentadol tartrate
Laboratorios Liconsa S.A.
Not marketed
Tapentadol Liconsa 200 mg prolonged-release tablets PA1239/029/005
Tapentadol tartrate
Laboratorios Liconsa S.A.
Not marketed
Tapentadol Liconsa 25 mg prolonged-release tablets PA1239/029/001
Tapentadol tartrate
Laboratorios Liconsa S.A.
Not marketed
Tapentadol Liconsa 250 mg prolonged-release tablets PA1239/029/006
Tapentadol tartrate
Laboratorios Liconsa S.A.
Not marketed
Tapentadol Liconsa 50 mg prolonged-release tablets PA1239/029/002
Tapentadol tartrate
Laboratorios Liconsa S.A.
Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 40 mg/12.5 mg tablets PA1239/025/001
Telmisartan, Hydrochlorothiazide
Laboratorios Liconsa S.A.
Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 80 mg/12.5 mg tablets PA1239/025/002
Telmisartan, Hydrochlorothiazide
Laboratorios Liconsa S.A.
Not marketed
Telmisartan/Hydrochlorothiazide Liconsa 80 mg/25 mg tablets PA1239/025/003
Telmisartan, Hydrochlorothiazide
Laboratorios Liconsa S.A.
Not marketed
Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 4 October 2026. https://priyalifescience.com/medicines/company/laboratorios-liconsa-s-a

Download this register
GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →
Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.